Search

Search Constraints

You searched for: Author/Creator Snell, Cameron

Search Results

1. Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine. Issue 7 (14th June 2019)